FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Amneal Pharmaceuticals of New York Phenoxybenzamine Hydrochloride Capsules Recall

Phenoxybenzamine Hydrochloride Capsules, USP 10mg, 100-count bottle, Rx only, Manufactu…

Amneal Pharmaceuticals of New York, LLC · Brookhaven, NY

Risk level
Class II
Reported by FDA
Feb 14, 2024
Recall ID
D-0319-2024
Check your lot numberHow we source this data

Summary

Amneal Pharmaceuticals of New York recalled Phenoxybenzamine Hydrochloride Capsules starting Jan 15, 2024. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0319-2024 on Feb 14, 2024. Reason: Failed Impurities/Degradation Specifications: Out of specification for unknown impurity. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specifications: Out of specification for unknown impurity.

Product description

Phenoxybenzamine Hydrochloride Capsules, USP 10mg, 100-count bottle, Rx only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd, Oral Solid Dosage Unit, Ahmedabad 382213, India, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC 60219-1502-01

Lot numbers, UPCs & expiration codes

Lot # AM221153, Exp. date 06/30/2024; AM230497, Exp. date 02/29/2025

Where it was sold

USA nationwide.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0319-2024
Classification
Class II
Status
Terminated
Recall initiated
Jan 15, 2024
FDA report date
Feb 14, 2024
Quantity
858 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Amneal Pharmaceuticals of New York, LLC

Original FDA data

Every field from FDA enforcement report D-0319-2024, exactly as published.

Show all FDA fields
City
Brookhaven
State
NY
Status
Terminated
Country
United States
Event ID
93813
Address
50 Horseblock Rd
Code information
Lot # AM221153, Exp. date 06/30/2024; AM230497, Exp. date 02/29/2025
Postal code
11719-9509
Report date
Feb 14, 2024
Product type
Drugs
Recall number
D-0319-2024
Classification
Class II
Recalling firm
Amneal Pharmaceuticals of New York, LLC
Product quantity
858 bottles
Termination date
Jan 31, 2025
Reason for recall
Failed Impurities/Degradation Specifications: Out of specification for unknown impurity.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Phenoxybenzamine Hydrochloride Capsules, USP 10mg, 100-count bottle, Rx only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd, Oral Solid Dosage Unit, Ahmedabad 382213, India, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC 60219-1502-01
Distribution pattern
USA nationwide.
Recall initiation date
Jan 15, 2024
Initial firm notification
Letter
Center classification date
Feb 8, 2024

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0319-2024, published Feb 14, 2024. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls